Both in Pharmaceuticals
Kardigan vs Omeros
Over the past year KARD returned −27.3% and OMER returned −4.4%; their daily moves had a correlation of 0.36.
KARD −27.3% OMER −4.4%Growth of $1, one year, split-adjusted
| Metric | KARD | OMER |
|---|---|---|
| Price | $13.47 | $17.47 |
| Market cap | $1.26B | $1.26B |
| Today | −0.96% | −0.11% |
| 1 month | −8.1% | −9.2% |
| 6 months | — | +20.0% |
| Year to date | — | +1.7% |
| 1 year | — | +126.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.2% |
| Net margin | — | 46.4% |
| P/E (TTM) | — | 10.1× |
| Price / sales | — | 32.9× |
| Net cash | $597.6M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 75.7% |
| Short % of float | 13.8% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).